Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 6, 2012, Pages 739-752

  Kerr, Paul M ^a   Tam, Raymond ^a   Narang, Deepak ^a   Potts, Kyle ^a   McMillan, Dane ^a   McMillan, Kale ^a   Plane, Frances ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Calcium activated potassium channels; Endothelial dysfunction; Endothelium; Nitric oxide; Oxidative stress

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ACTIVATED POTASSIUM CHANNEL; NAPHTHO[1,2 D]THIAZOL 2 YLAMINE; NITRIC OXIDE; SKA 31; UNCLASSIFIED DRUG;

ARTERY DIAMETER; CARDIOVASCULAR DISEASE; CELL MEMBRANE; DIABETES MELLITUS; DRUG TARGETING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKING; SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARTERIES; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR TARGETED THERAPY; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED;

EID: 84870710884     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-075     Document Type: Review

References (140)

1. Absi, M., Burnham, M.P., Weston, A.H., Harno, E., Rogers, M., and Edwards, G. 2007. Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin-rich domains. Br. J. Pharmacol. 151(3): 332-340. doi:10.1038/sj.bjp.0707222. PMID:17450174.
2. Adams, D.J., Barakeh, J., Laskey, R., and van Breemen, C. 1989. Ion channels and tregulation of intracellular calcium in vascular endothelial cells. FASEB J. 3(12): 2389-2400. PMID:2477294.
3. Adeagbo, A.S. 1999. 1-Ethyl-2-benzimidazolinone stimulates endothelial K(Ca) channels and nitric oxide formation in rat mesenteric vessels. Eur. J. Pharmacol. 379(2-3): 151-159. doi:10.1016/S0014-2999(99)00489-6. PMID:10497901.
4. Aggarwal, S., Gross, C.M., Kumar, S., Datar, S., Oishi, P., Kalkan, G., et al. 2011. Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration. J. Cell. Physiol. 226(12): 3104-3113. doi:10.1002/jcp.22692. PMID:21351102.
5. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y.H., Takada, J., et al. 2004. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation, 109(2): 227-233. doi:10.1161/01.CIR.0000105680.92873.70. PMID:14718399.
6. +. Circ. Res. 83(7): 730-737.PMID:9758643.
7. Allen, T., Iftinca, M., Cole, W.C., and Plane, F. 2002. Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. J. Physiol. 545(3): 975-986. doi:10.1113/jphysiol.2002.031823. PMID:12482900.
8. Bachschmid, M., Thurau, S., Zou, M.H., and Ullrich, V. 2003. Endothelial cell activation by endotoxin involves superoxide/NOmediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J. 17(8): 914-916.PMID:12670882.
9. Bahia, P.K., Suzuki, R., Benton, D.C., Jowett, A.J., Chen, M.X., Trezise, D.J., et al. 2005. A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes. J. Neurosci. 25(14): 3489-3498. doi:10.1523/JNEUROSCI.0597-05.2005. PMID:15814779.
10. Bakker, E.N., and Sipkema, P. 1997. Components of acetylcholineinduced dilation in isolated rat arterioles. Am. J. Physiol. 273(4): H1848-H1853. PMID:9362252.
11. Barry-Lane, P.A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S.M., Yeh, E.T., and Runge, M.S. 2001. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108(10): 1513-1522.PMID:11714743.
12. Beckman, J.S., and Koppenol, W.H. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271(5): C1424-C1437.PMID:8944624.
13. Bedard, K., and Krause, K.H. 2007. The NOX family of ROSgenerating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87(1): 245-313. doi:10.1152/physrev.00044.2005. PMID:17237347.
14. + channels: from protein complexes to function. Physiol. Rev. 90(4): 1437-1459. doi:10.1152/physrev.00049.2009. PMID:20959620.
15. Bogle, R.G., Coade, S.B., Moncada, S., Pearson, J.D., and Mann, G.E. 1991. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem. Biophys. Res. Commun. 180(2): 926-932. doi:10.1016/S0006-291X(05)81154-4. PMID:1659406.
16. Brähler, S., Kaistha, A., Schmidt, V.J., Wölfle, S.E., Busch, C., Kaistha, B.P., et al. 2009. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation, 119(17): 2323-2332. doi:10.1161/CIRCULATIONAHA.108.846634. PMID:19380617.
17. Brøndum, E., Kold-Petersen, H., Simonsen, U., and Aalkjaer, C. 2010. NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats. Br. J. Pharmacol. 159(1): 154-165. doi:10.1111/j.1476-5381.2009.00525.x. PMID:20015296.
18. Bukhari, I.A., Gauthier, K.M., Jagadeesh, S.G., Sangras, B., Falck, J.R., and Campbell, W.B. 2011. 14,15-Dihydroxy-eicosa-5(Z)-enoicacid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries. J. Pharmacol. Exp. Ther. 336(1): 47-55. doi:10.1124/jpet.110.169797. PMID:20881018.
19. Burnham, M.P., Bychkov, R., Feletou, M., Richards, G.R., Vanhoutte, P.M., Weston, A.H., and Edwards, G. 2002. Characterization of an apamin-sensitive small conductance Ca2+-activated K+ channel in porcine coronary artery endothelium: relevance to EDHF. Br. J. Pharmacol. 135(5): 1133-1143. doi:10.1038/sj.bjp.0704551. PMID:11877319.
20. + channel-dependent EDHF responses in type II diabetic ZDF rats. Br. J. Pharmacol. 148(4): 434-441. doi:10.1038/sj.bjp.0706748. PMID:16682967.
21. + channel in porcine coronary endothelium: relevance to EDHF. Br. J. Pharmacol. 137(8): 1346-1354. doi:10.1038/sj.bjp.0705057. PMID:12466245.
22. Campbell, W.B., Gebremedhin, D., Pratt, P.F., and Harder, D.R. 1996. Identification of epoxyeicosatrienoic acids as endotheliumderived hyperpolarizing factors. Circ. Res. 78(3): 415-423.PMID:8593700.
23. Ceroni, L., Ellis, A., Wiehler, W.B., Jiang, Y.F., Ding, H., and Triggle, C.R. 2007. Calcium-activated potassium channel and connexin expression in small mesenteric arteries from eNOSdeficient (eNOS-/-) and eNOS expressing (eNOS+/+) mice. Eur. J. Pharmacol. 560(2-3): 193-200. doi:10.1016/j.ejphar.2007.01.018. PMID:17300779.
24. Chatterjee, S., Browning, E.A., Hong, N., Debolt, K., Sorokina, E.M., Liu, W., et al. 2012. Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am. J. Physiol. Heart Circ. Physiol. 302(1): H105-H114. doi:10.1152/ajpheart.00298.2011. PMID:22003059.
25. Chauhan, S., Rahman, A., Nilsson, H., Clapp, L., MacAllister, R., and Ahluwalia, A. 2003. NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc. Res. 57(1): 207-216. doi:10.1016/S0008-6363(02)00611-9. PMID:12504830.
26. Chen, K., Kirber, M.T., Xiao, H., Yang, Y., and Keaney, J.F., Jr. 2008. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181(7): 1129-1139. doi:10.1083/jcb.200709049. PMID:18573911.
27. Chin-Dusting, J.P., Willems, L., and Kaye, D.M. 2007. L-Arginine transporters in cardiovascular disease: a novel therapeutic target. Pharmacol. Ther. 116(3): 428-436. doi:10.1016/j.pharmthera.2007.08.001. PMID:17915331.
28. Chrissobolis, S., Miller, A.A., Drummond, G.R., Kemp-Harper, B.K., and Sobey, C.G. 2011. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front. Biosci. 16(1): 1733-1745. doi:10.2741/3816. PMID:21196259.
29. 2+ in arteriolar endothelial cells. Microcirculation, 12(2): 169-182. doi:10.1080/10739680590904973. PMID:15824039.
30. Dal-Ros, S., Oswald-Mammosser, M., Pestrikova, T., Schott, C., Boehm, N., Bronner, C., et al. 2010. Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. Gastroenterology, 138(4): 1574-1584. doi:10.1053/j.gastro.2009.10.040. PMID:19879274.
31. Dalsgaard, T., Kroigaard, C., Bek, T., and Simonsen, U. 2009. Role of calcium-activated potassium channels with small conductance in bradykinin-induced vasodilation of porcine retinal arterioles. Invest. Ophthalmol. Vis. Sci. 50(8): 3819-3825. doi:10.1167/iovs.08-3168. PMID:19255162.
32. Dalsgaard, T., Kroigaard, C., Misfeldt, M., Bek, T., and Simonsen, U. 2010. Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles. Br. J. Pharmacol. 160(6): 1496-1508.PMID:20590639.
33. Damkjaer, M., Nielsen, G., Bodendiek, S., Staehr, M., Gramsbergen, J.B., de Wit, C., et al. 2012. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br. J. Pharmacol. 165(1): 223-234. doi:10.1111/j.1476-5381.2011.01546.x. PMID:21699504.
34. de Wit, C., and Griffith, T.M. 2010. Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch. 459(6): 897-914. doi:10.1007/s00424-010-0830-4. PMID:20379740.
35. Di Lisa, F., Kaludercic, N., Carpi, A., Menabò, R., and Giorgio, M. 2009. Mitochondria and vascular pathology. Pharmacol. Rep. 61(1): 123-130.PMID:19307700.
36. Dikalov, S.I., Dikalova, A.E., Bikineyeva, A.T., Schmidt, H.H., Harrison, D.G., and Griendling, K.K. 2008. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 45(9): 1340-1351. doi:10.1016/j.freeradbiomed.2008.08.013. PMID:18760347.
37. + channels terminates and protects against atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3(4): 380-390. doi:10.1161/CIRCEP.110.957407. PMID:20562443.
38. + channel inhibition. Hypertension, 57(6): 1129-1135. doi:10.1161/HYPERTENSIONAHA.111.170613. PMID:21502564.
39. Dogan, A., Yarlioglues, M., Kaya, M.G., Karadag, Z., Dogan, S., Ardic, I., et al. 2011. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press. 20(3): 182-187. doi:10.3109/08037051.2010.538977. PMID:21133824.
40. Doughty, J.M., Plane, F., and Langton, P.D. 1999. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am. J. Physiol. 276(3): H1107-H1112.PMID:10070099.
41. -/- mice. Cardiovasc. Res. 94(1): 20-29. doi:10.1093/cvr/cvs026. PMID:22287576.
42. Drummond, G.R., Selemidis, S., Griendling, K.K., and Sobey, C.G. 2011. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10(6): 453-471. doi:10.1038/nrd3403. PMID:21629295.
43. Duffy, S.M., Lawley, W.J., Conley, E.C., and Bradding, P. 2001. Resting and activation-dependent ion channels in human mast cells. J. Immunol. 167(8): 4261-4270.PMID:11591748.
44. +-channels suppresses EDHF-mediated vasodilation. Br. J. Pharmacol. 138(4): 594-601. doi:10.1038/sj.bjp.0705075. PMID:12598413.
45. El-Remessy, A.B., Behzadian, M.A., Abou-Mohamed, G., Franklin, T., Caldwell, R.W., and Caldwell, R.B. 2003. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am. J. Pathol. 162(6): 1995-2004. doi:10.1016/S0002-9440(10)64332-5. PMID:12759255.
46. Fanger, C.M., Ghanshani, S., Logsdon, N.J., Rauer, H., Kalman, K., Zhou, J., et al. 1999. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J. Biol. Chem. 274(9): 5746-5754. doi:10.1074/jbc.274.9.5746.PMID:10026195.
47. Fanger, C.M., Rauer, H., Neben, A.L., Miller, M.J., Rauer, H., Wulff, H., et al. 2001. Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J. Biol. Chem. 276(15): 12249-12256. doi:10.1074/jbc.M011342200. PMID:11278890.
48. Fay, A.J., Qian, X., Jan, Y.N., and Jan, L.Y. 2006. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc. Natl. Acad. Sci. U. S.A. 103(46): 17548-17553. doi:10.1073/pnas.0607914103. PMID:17085590.
49. Fitzgerald, S.M., Kemp-Harper, B.K., Parkington, H.C., Head, G.A., and Evans, R.G. 2007. Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293(2): R707-R713. doi:10.1152/ajpregu.00807.2006. PMID:17522117.
50. Förstermann, U. 2010. Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459(6): 923-939. doi:10.1007/s00424-010-0808-2. PMID:20306272.
51. Förstermann, U., and Münzel, T. 2006. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 113(13): 1708-1714. doi:10.1161/CIRCULATIONAHA.105.602532. PMID:16585403.
52. + channels of small and intermediate conductance control eNOS activation through NADPH oxidase. Free Radic. Biol. Med. 52(5): 860-870. doi:10.1016/j.freeradbiomed.2011.11.036. PMID:22210378.
53. Gao, Y. 2010. The multiple actions of NO. Pflugers Arch. 459(6): 829-839. doi:10.1007/s00424-009-0773-9. PMID:20024580.
54. + channel blockers involved in EDHFmediated responses in rat superior mesenteric artery. Br. J. Pharmacol. 134(5): 1021-1028. doi:10.1038/sj.bjp.0704348. PMID:11682450.
55. Görlach, A., Brandes, R.P., Nguyen, K., Amidi, M., Dehghani, F., and Busse, R. 2000. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87(1): 26-32. PMID:10884368.
56. Grgic, I., Kaistha, B.P., Hoyer, J., and Köhler, R. 2009. Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery. Br. J. Pharmacol. 157(4): 509-526. doi:10.1111/j.1476-5381.2009.00132.x. PMID:19302590.
57. Gryglewski, R.J. 2008. Prostacyclin among prostanoids. Pharmacol. Rep. 60(1): 3-11. PMID:18276980.
58. Harrison, R. 2002. Structure and function of xanthine oxidoreductase: where are we now? Free Radic. Biol. Med. 33(6): 774-797. doi:10.1016/S0891-5849(02)00956-5. PMID:12208366.
59. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 360(9326): 23-33.
60. Herrik, K.F., Redrobe, J.P., Holst, D., Hougaard, C., Sandager- Nielsen, K., Nielsen, A.N., et al. 2012. CyPPA, a positive SK3/SK2 modulator, reduces activity of dopaminergic neurons, inhibits dopamine release, and counteracts hyperdopaminergic behaviors induced by methylphenidate. Front. Pharmacol. 3: 1-12. doi:10.3389/fphar.2012.00011. PMID:22347859.
61. Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H.H., Busse, R., Schröder, K., and Brandes, R.P. 2008. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension, 51(2): 211-217. doi:10.1161/HYPERTENSIONAHA.107.100214. PMID:18086956.
62. Hilgers, R.H., and Webb, R.C. 2007. Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 292(5): H2275-H2284. doi:10.1152/ajpheart.00949.2006. PMID:17209000.
63. + channels. Am. J. Physiol. Heart Circ. Physiol. 291(1): H216-H222. doi:10.1152/ajpheart.01383. 2005. PMID:16473954.
64. + channels. Br. J. Pharmacol. 151(5): 655-665. doi:10.1038/sj.bjp.0707281. PMID:17486140.
65. Huie, R.E., and Padmaja, S. 1993. The reaction of NO with superoxide. Free Radic. Res. Commun. 18(4): 195-199. doi:10. 3109/10715769309145868. PMID:8396550.
66. 2+ sensitivity of SK channels. Eur. J. Neurosci. 29(9): 1883-1895. doi:10.1111/j.1460-9568.2009.06735.x. PMID:19473240.
67. Kleger, A., Seufferlein, T., Malan, D., Tischendorf, M., Storch, A., Wolheim, A., et al. 2010. Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation, 122(18): 1823-1836. doi:10.1161/CIRCULATIONAHA.110.971721.PMID:20956206.
68. Köhler, R., and Hoyer, J. 2007. The endothelium-derived hyperpolarizing factor: insights from genetic animal models. Kidney Int. 72(2): 145-150. doi:10.1038/sj.ki.5002303. PMID:17457372.
69. + channels in human mesenteric artery: a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ. Res. 87(6): 496-503.PMID:10988242.
70. Köhler, R., Eichler, I., Schönfelder, H., Grgic, I., Heinau, P., Si, H., and Hoyer, J. 2005. Impaired EDHF-mediated vasodilation and function of endothelial Ca-activated K channels in uremic rats. Kidney Int. 67(6): 2280-2287. doi:10.1111/j.1523-1755.2005.00331.x. PMID:15882269.
71. Köhler, R., Kaistha, B.P., and Wulff, H. 2010. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin. Ther. Targets, 14(2): 143-155. doi:10.1517/ 14728220903540257. PMID:20055714.
72. Korkmaz, S., Radovits, T., Barnucz, E., Neugebauer, P., Arif, R., Hirschberg, K., et al. 2009. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta. Eur. J. Pharmacol. 615(1-3): 155-162.PMID:19482016.
73. Kurian, M.M., Berwick, Z.C., and Tune, J.D. 2011. Contribution of IKCa channels to the control of coronary blood flow. Exp. Biol. Med. (Maywood), 236(5): 621-627. doi:10.1258/ebm.2011.010351. PMID:21502192.
74. Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., et al. 2002. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension, 40(4): 511-515. doi:10.1161/01.HYP.0000032100.23772.98. PMID:12364355.
75. Landmesser, U., Dikalov, S., Price, S.R., McCann, L., Fukai, T., Holland, S.M., et al. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111(8): 1201-1209.PMID:12697739.
76. Ledoux, J., Werner, M.E., Brayden, J.E., and Nelson, M.T. 2006. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda), 21(1): 69-78. doi:10.1152/physiol.00040.2005. PMID:16443824.
77. + channels in murine endothelial cells: block by intracellular calcium and magnesium. J. Gen. Physiol. 131(2): 125-135. doi:10.1085/jgp.200709875. PMID:18195387.
78. + channels and calmodulin: cell surface expression and gating. J. Biol. Chem. 278(28): 25940-25946. doi:10.1074/jbc.M302091200. PMID:12734181.
79. Li, L., Bressler, B., Prameya, R., Dorovini-Zis, K., and Van Breemen, C. 1999. Agonist-stimulated calcium entry in primary cultures of human cerebral microvascular endothelial cells. Microvasc. Res. 57(3): 211-226. doi:10.1006/mvre.1998.2131. PMID:10329249.
80. Liang, C.F., Au, A.L., Leung, S.W., Ng, K.F., Félétou, M., Kwan, Y. W., et al. 2010. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle. J. Pharmacol. Exp. Ther. 334(1): 223-231. doi:10.1124/jpet.110.166652. PMID:20332186.
81. + channel activity in smooth muscle of human coronary arterioles. Circ. Res. 91(11): 1070-1076. doi:10.1161/01.RES.0000046003.14031.98. PMID:12456494.
82. Lückhoff, A., and Busse, R. 1990. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflugers Arch. 416(3): 305-311. doi:10.1007/BF00392067. PMID:2381766.
83. Ma, X., Cheng, K.T., Wong, C.O., O'Neil, R.G., Birnbaumer, L., Ambudkar, I.S., and Yao, X. 2011. Heteromeric TRPV4-C1 channels contribute to store-operated Ca(2+) entry in vascular endothelial cells. Cell Calcium, 50(6): 502-509. doi:10.1016/j.ceca.2011.08.006. PMID:21930300.
84. Maneen, M.J., and Cipolla, M.J. 2007. Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and Factin. Am. J. Physiol. Heart Circ. Physiol. 292(2): H1042-H1050. doi:10.1152/ajpheart.00800.2006. PMID:17040976.
85. Marchenko, S.M., and Sage, S.O. 1996. Calcium-activated potassium channels in the endothelium of intact rat aorta. J. Physiol. 492(1): 53-60.PMID:8730582.
86. Marrelli, S.P., Eckmann, M.S., and Hunte, M.S. 2003. Role of endothelial intermediate conductance KCa channels in cerebral EDHF-mediated dilations. Am. J. Physiol. Heart Circ. Physiol. 285(4): H1590-H1599.PMID:12805022.
87. Matsuzaki, I., Chatterjee, S., Debolt, K., Manevich, Y., Zhang, Q., and Fisher, A.B. 2005. Membrane depolarization and NADPH oxidase activation in aortic endothelium during ischemia reflect altered mechanotransduction. Am. J. Physiol. Heart Circ. Physiol. 288(1): H336-H343. doi:10.1152/ajpheart.00025.2004. PMID:15331375.
88. 2+ increases are independent of membrane potential in pressurized rat mesenteric arteries. Cell Calcium, 38 (1): 23-33. doi:10.1016/j.ceca.2005.03.007. PMID:15907999.
89. Michell, D.L., Andrews, K.L., and Chin-Dusting, J.P. 2011. Endothelial dysfunction in hypertension: the role of arginase. Front. Biosci. S3(1): 946-960. doi:10.2741/199. PMID:21622244.
90. Miura, H., Liu, Y., and Gutterman, D.D. 1999. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation, 99(24): 3132-3138.PMID:10377076.
91. Mohazzab, K.M., Kaminski, P.M., and Wolin, M.S. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266(6): H2568-H2572.PMID:8024019.
92. Montezano, A.C., and Touyz, R.M. 2012. Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin. Pharmacol. Toxicol. 110(1): 87-94. doi:10.1111/j.1742-7843.2011.00785.x. PMID:21883939.
93. Morio, Y., Homma, N., Takahashi, H., Yamamoto, A., Nagaoka, T., Sato, K., et al. 2007. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. J. Vasc. Res. 44(4): 325-335. doi:10.1159/000101778. PMID:17438361.
94. Oltman, C.L., Coppey, L.J., Gellett, J.S., Davidson, E.P., Lund, D.D., and Yorek, M.A. 2005. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am. J. Physiol. Endocrinol. Metab. 289(1): E113-E122. doi:10.1152/ajpendo.00594.2004. PMID:15727946.
95. Palmer, R.M., Ferrige, A.G., and Moncada, S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327(6122): 524-526. doi:10.1038/327524a0. PMID:3495737.
96. -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br. J. Pharmacol. 136(2): 255-263. doi:10.1038/sj.bjp.0704683. PMID:12010774.
97. Pannirselvam, M., Ding, H., Anderson, T.J., and Triggle, C.R. 2006. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 551(1-3): 98-107. doi:10.1016/j.ejphar.2006.08.086. PMID:17027963.
98. Paravicini, T.M., and Touyz, R.M. 2008. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care, 31(Suppl. 2): S170-S180. doi:10.2337/dc08-s247. PMID:18227481.
99. Paravicini, T.M., Gulluyan, L.M., Dusting, G.J., and Drummond, G.R. 2002. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 91(1): 54-61. doi:10.1161/01.RES.0000024106.81401.95. PMID:12114322.
100. Park, Y., Capobianco, S., Gao, X., Falck, J.R., Dellsperger, K.C., and Zhang, C. 2008. Role of EDHF in type 2 diabetes-induced endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 295(5): H1982-H1988. doi:10.1152/ajpheart.01261.2007. PMID: 18790831.
101. Patel, S., Vemula, J., Konikkat, S., Barthwal, M.K., and Dikshit, M. 2009. Ion channel modulators mediated alterations in NO-induced free radical generation and neutrophil membrane potential. Free Radic. Res. 43(5): 514-521. doi:10.1080/10715760902887276. PMID:19391055.
102. Petheö, G., and Demaurex, N. 2005. Voltage- and NADPHdependence of electron currents generated by the phagocytic NADPH oxidase. Biochem. J. 388(2): 485-491. doi:10.1042/BJ20041889. PMID:15689187.
103. Plane, F., and Cole, W.C. 2006. Release of nitric oxide is modulated by endothelial cell membrane potential in rat basilar artery. FASEB J. 20(5): 738.12. [abstract.]
104. Plane, F., Wiley, K.E., Jeremy, J.Y., Cohen, R.A., and Garland, C.J. 1998. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery. Br. J. Pharmacol. 123(7): 1351-1358. doi:10.1038/sj.bjp.0701746. PMID:9579730.
105. + channels contribute to acetylcholine-induced, NO-dependent vasorelaxation of rat aorta. Med. Sci. Monit. 7(6): 1129-1136.PMID:11687720.
106. Rath, G., Dessy, C., and Feron, O. 2009. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation. J. Physiol. Pharmacol. 60(Suppl. 4): 105-109.PMID:20083858.
107. Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom- Ruiz, S., et al. 2011. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31(6): 1368-1376. doi:10.1161/ATVBAHA.110.219238. PMID:21415386.
108. Remillard, C.V., and Yuan, J.X. 2006. Transient receptor potential channels and caveolin-1: good friends in tight spaces. Mol. Pharmacol. 70(4): 1151-1154. doi:10.1124/mol.106.029280. PMID:16873578.
109. Riddell, D.R., and Owen, J.S. 1997. Nitric oxide and platelet aggregation. Vitam. Horm. 57: 25-48. doi:10.1016/S0083-6729(08)60639-1. PMID:10232045.
110. Sakai, T. 1990. Acetylcholine induces Ca-dependent K currents in rabbit endothelial cells. Jpn. J. Pharmacol. 53(2): 235-246. doi:10.1254/jjp.53.235. PMID:2385008.
111. Sandow, S.L., Neylon, C.B., Chen, M.X., and Garland, C.J. 2006. Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function? J. Anat. 209(5): 689-698. doi:10.1111/j.1469-7580.2006.00647.x. PMID:17062025.
112. Sandow, S.L., Haddock, R.E., Hill, C.E., Chadha, P.S., Kerr, P.M., Welsh, D.G., and Plane, F. 2009. What's where and why at a vascular myoendothelial microdomain signalling complex. Clin. Exp. Pharmacol. Physiol. 36(1): 67-76. doi:10.1111/j.1440-1681.2008.05076.x. PMID:19018806.
113. Sankaranarayanan, A., Raman, G., Busch, C., Schultz, T., Zimin, P.I., Hoyer, J., et al. 2009. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol. Pharmacol. 75(2): 281-295. doi:10.1124/mol.108.051425. PMID:18955585.
114. Schilling, W.P. 1989. Effect of membrane potential on cytosolic calcium of bovine aortic endothelial cells. Am. J. Physiol. 257(3): H778-H784. PMID:2782436.
115. Schreiber, M., and Salkoff, L. 1997. A novel calcium-sensing domain in the BK channel. Biophys. J. 73(3): 1355-1363. doi:10.1016/S0006-3495(97)78168-2. PMID:9284303.
116. + channels directly control agonistevoked nitric oxide synthesis in human vascular endothelial cells. Am. J. Physiol. Cell Physiol. 293(1): C458-C467. doi:10.1152/ajpcell.00036.2007. PMID:17459950.
117. Sheng, J.Z., Ella, S., Davis, M.J., Hill, M.A., and Braun, A.P. 2009. Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation. FASEB J. 23(4): 1138-1145. doi:10.1096/fj.08-120451. PMID:19074509.
118. Shi, Y., Ku, D.D., Man, R.Y., and Vanhoutte, P.M. 2006. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats. J. Pharmacol. Exp. Ther. 318(1): 276-281. doi:10.1124/jpet.105.099739. PMID:16565165.
119. + channel. Circ. Res. 99(5): 537-544. doi:10.1161/01.RES.0000238377.08219.0c. PMID:16873714.
120. Simonsen, U., Wadsworth, R.M., Buus, N.H., and Mulvany, M.J. 1999. In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J. Physiol. 516(1): 271-282. doi:10.1111/j.1469-7793.1999.271aa.x. PMID:10066940.
121. Singh, S., Syme, C.A., Singh, A.K., Devor, D.C., and Bridges, R.J. 2001. Benzimidazolone activators of chloride secretion: Potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. J. Pharmacol. Exp. Ther. 296(2): 600-611. PMID:11160649.
122. Song, C., Al-Mehdi, A.B., and Fisher, A.B. 2001. An immediate endothelial cell signaling response to lung ischemia. Am. J. Physiol. Lung Cell. Mol. Physiol. 281(4): L993-L1000. PMID:11557603.
123. + channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. Br. J. Pharmacol. 149 (5): 560-572. doi:10.1038/sj.bjp.0706886. PMID:16967048.
124. Stankevičius, E., Dalsgaard, T., Kroigaard, C., Beck, L., Boedtkjer, E., Misfeldt, M.W., et al. 2011. Opening of small and intermediate calcium-activated potassium channels induces relaxation mainly mediated by nitric-oxide release in large arteries and endotheliumderived hyperpolarizing factor in small arteries from rat. J. Pharmacol. Exp. Ther. 339(3): 842-850. doi:10.1124/jpet.111.179242. PMID:21880870.
125. Støen, R., Lossius, K., and Karlsson, J.O. 2003. Acetylcholineinduced vasodilation may depend entirely upon NO in the femoral artery of young piglets. Br. J. Pharmacol. 138(1): 39-46. doi:10. 1038/sj.bjp.0705001. PMID:12522071.
126. + channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim. Biophys. Acta, 1665(1-2): 1-5. doi:10.1016/j.bbamem.2004.07.006. PMID:15471565.
127. Szabó, C., Ischiropoulos, H., and Radi, R. 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6(8): 662-680. doi:10.1038/nrd2222.PMID:17667957.
128. + (SK3) channels modulates arterial tone and blood pressure. Circ. Res. 93(2): 124-131.doi:10.1161/01.RES.0000081980.63146.69. PMID:12805243.
129. + channel (KCa3.1) in vascular disease. Cardiovasc. Hematol. Agents Med. Chem. 7(1): 1-11. doi:10.2174/187152509787047649. PMID:19149539.
130. Tomioka, H., Hattori, Y., Fukao, M., Sato, A., Liu, M., Sakuma, I., et al. 1999. Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions. J. Vasc. Res. 36(4): 311-320. doi:10.1159/000025659. PMID:10474044.
131. Turrens, J.F. 2003. Mitochondrial formation of reactive oxygen species. J. Physiol. 552(2): 335-344. doi:10.1113/jphysiol.2003.049478. PMID:14561818.
132. Ueda, A., Ohyanagi, M., Koida, S., and Iwasaki, T. 2005. Enhanced release of endothelium-derived hyperpolarizing factor in small coronary arteries from rats with congestive heart failure. Clin. Exp. Pharmacol. Physiol. 32(8): 615-621. doi:10.1111/j.0305-1870.2005.04240.x. PMID:16120187.
133. Villar, I.C., Panayiotou, C.M., Sheraz, A., Madhani, M., Scotland, R.S., Nobles, M., et al. 2007. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc. Res. 74(3): 515-525. doi:10.1016/j.cardiores.2007.02.032. PMID:17391657.
134. + channel (rSK4) of colonic crypts. Pflugers Arch. 438(4): 437-444. doi:10.1007/s004240051059. PMID:10519135.
135. Willette, R.N., Bao, W., Nerurkar, S., Yue, T.L., Doe, C.P., Stankus, G., et al. 2008. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: part 2. J. Pharmacol. Exp. Ther. 326(2): 443-452. doi:10.1124/jpet.107.134551. PMID:18499744.
136. Wulff, H., Kolski-Andreaco, A., Sankaranarayanan, A., Sabatier, J.-M., and Shakkottai, V. 2007. Modulators of small- and intermediateconductance calcium-activated potassium channels and their therapeutic indications. Curr. Med. Chem. 14(13): 1437-1457. doi:10.2174/092986707780831186. PMID:17584055.
137. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273(40): 25804-25808. doi:10.1074/jbc.273.40.25804. PMID:9748253.
138. Yang, B., and Rizzo, V. 2007. TNF-a potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292(2): H954-H962. doi:10.1152/ajpheart.00758.2006. PMID:17028163.
139. Zharikov, S.I., Herrera, H., and Block, E.R. 1997. Role of membrane potential in hypoxic inhibition of L-arginine uptake by lung endothelial cells. Am. J. Physiol. 272(1): L78-L84. PMID:9038906.
140. Zygmunt, P.M., and Högestätt, E.D. 1996. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol. 117(7): 1600-1606.PMID:8730760.